Y2V-43547-45287
3 vaccinations
4 coded responses
9 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 563 / MN
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-02-17
Dose 2 — Pfizer-BioNTech
-
2021-03-12
Registered in v-safe
-
2021-03-12
Survey response — day 21, dose 2MedDRA: Dyspnoea, Dyspnoea exertional, Fatigue, Heart rate increased, Pain, Painful respiration, Red blood cell sedimentation rate increased, White blood cell count increased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Fast heart rate, difficulty and pain taking a deep breath, feel like I cant get a breath if moving around, elevated WBC, ESR 49, achy, extremely fatiguedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-17
-
2021-03-24
Survey response — day 35, dose 2MedDRA: Arrhythmia, Dyspnoea, Fatigue, Office visit, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Arrythmyia, tachycardia, difficulty breathing, very fatigued · Healthcare visit (other): Cardiologist, electro cardio versionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-31
-
2021-05-21
Survey response — 3 months, dose 2MedDRA: Chest pain, Heart rate increased, Hypoacusis, Pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Loss of some hearing, increased heart rate, some dull pain in the chest with a deep breath.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-18
-
2021-12-06
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-12-13
Dose 3 — Janssen/Johnson & Johnson
- 2022-02-17
-
2022-03-14
Survey response — 3 months, dose 3MedDRA: Arthralgia, Chest pain, Heart rate increased, Neck pain, Painful respiration, Palpitations, Pericarditis, Pleurisy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pleurisy, pericarditis, palpitations, faster heart rate, pain in shoulder, neck and chest when breathingMedDRA releases: 2024-11 · check-in free text available
- 2022-12-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech | |
| 3 | 2021-12-13 | Janssen/Johnson & Johnson | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-12 | Successful | Reported to VAERS voluntarily prior to GDIT contact |
| 2021-03-24 | Successful 2021-12-06 |
Reported to VAERS voluntarily prior to GDIT contact |
Free text
Release 5 — day 21, dose 2
Symptoms: Fast heart rate, difficulty and pain taking a deep breath, feel like I cant get a breath if moving around, elevated WBC, ESR 49, achy, extremely fatigued
Release 6 — day 35, dose 2
Symptoms: Arrythmyia, tachycardia, difficulty breathing, very fatigued
Healthcare visit (other): Cardiologist, electro cardio version
Release 8 — 3 months, dose 2
Symptoms: Loss of some hearing, increased heart rate, some dull pain in the chest with a deep breath.
Release 11 — 3 months, dose 3
Symptoms: Pleurisy, pericarditis, palpitations, faster heart rate, pain in shoulder, neck and chest when breathing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Arrhythmia | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Hypoacusis | ✓ | ✓ | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Painful respiration | ✓ | ✓ | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Pericarditis | · | · | ✓ |
| SD | Pleurisy | · | · | ✓ |
| SD | Red blood cell sedimentation rate increased | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SD | White blood cell count increased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release